Table 2.

European standardized incidence rates for melanomas of different locations in 3-year periods between 1989 and 2006

Gender and locationPeriodEAPC
1989-19911992-19941995-19971998-20002001-20032004-2006
nESR*nESR*nESR*nESR*nESR*nESR*mean95% CI
Men
    Skin1,90088.52,15496.02,600111.63,007124.13,605142.64,457168.9+4.4%+3.9 to +4.9%
    Mucosal281.95292.54381.97473.21411.67433.14+0.9%−2.0 to +3.9%
    Ear-nose-throat180.88170.81160.72231.00240.97240.90+1.1%−4.4 to +7.1%
    Ocularn.a.n.a.n.a.n.a.n.a.n.a.n.a.n.a.n.a.n.a.28910.92n.a.n.a.
Women
    Skin2.91124.73.15130.83.7150.84.06161.24.89189.55.69213.6+3.6%+2.9 to +4.2%
    Mucosal712.89873.65832.581113.211042.411042.78+1.8%−0.5 to +4.2%
    Ear-nose-throat150.60220.88220.87301.19250.97250.91+2.8%−0.1 to +6.8%
    Vulvan.a.n.a.n.a.n.a.351.42552.12451.72471.64+0.3%−2.6 to +3.4%
    Ocularn.a.n.a.n.a.n.a.n.a.n.a.n.a.n.a.n.a.n.a.2347.94n.a.n.a.
  • *European standardized incidence rate, expressed in 1 per 1.000.000 person-years.

  • Subcategories of the extracutaneous melanomas that were tested for an incidence trend were: mucosal melanomas, including all mucosal melanomas (ear-nose-throat, genitals, vulva, gastrointestinal tract, lungs and urinary tract); ear-nose-throat, including only the sinonasal and oropharyngeal mucosal melanomas (larynx, lip, pharynx, oral cavity, nasal cavity, middle ear and sinuses); and vulvar mucosal melanomas.

  • Before 1993 there were no separate ICD codes registered for vulvar melanomas. Both in 1993 and 1994, 16 vulvar melanomas were registered.